BioSpace News Archive

SML Genetree announced today that it has received Emergency Use Authorization (EUA) from the U.S. FDA for the use of its Ezplex SARS-CoV-2 G Kit, a molecular diagnostic test for the qualitative detection of RNA from SARS-CoV-2 from nasopharyngeal swabs, oropharyngeal swabs and sputum specimens as well as for use in pooled pati

The National Evaluation System for health Technology Coordinating Center (NESTcc), an initiative of the Medical Device Innovation Consortium (MDIC), today announced the Regenstrief Institute as the newest Network Collaborator to join the NESTcc Research Network.

The Pulmonary Fibrosis Foundation (PFF), the nation’s leading pulmonary fibrosis (PF) education and advocacy organization, has announced United Therapeutics’ sponsorship of the PFF Registry, a research resource that tracks clinical data, blood samples and patient-reported outcomes from individuals living with PF nationwide.

Grant funding to grassroots organizations will help address structural racism and practices that prevent communities of color from achieving good health and wellbeing

Saskatoon, Saskatchewan--(Newsfile Corp. - January 14, 2021) - MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce that it has received over C$1.5 million from the exercise of approximately 3.2 million common share purchase warrants at an average weighted exercise price of C$0.48 per share.

Growing demand for reliable early-stage diagnosis of chronic ailments is likely to add impetus to molecular diagnostics market growth over the forecast spell.

The next generation sequencing (NGS) market growth will be fostered by the introduction of efficient and advanced sequencing technologies and its extensive application in analyzing DNA.

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces the appointment of Gaëlle Stadtler as Director of Human Resources

The exponentially increasing popularity of birth control measures to control the risk of unintended pregnancies is amplifying the demand for safe and reliable contraceptive solutions.

Hoag Memorial Hospital Presbyterian is building upon its personalized, science-based approach to cancer care with the launch of its Molecular Imaging and Therapy Program, led by nationally recognized expert Gary A. Ulaner, M.D., Ph.D.